Searched for
WOCKHARDT Q3
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
- Wockhardt Q2 Results: Net loss narrows to Rs 16 crore, revenue rises 7%Drugmaker Wockhardt on Wednesday reported a net loss of Rs 16 crore in Q2FY25 led by improved performance across UK, India and emerging mar...
- Wockhardt Q3 Results: Firm reports cons loss at Rs 102 croreConsolidated revenue from operations stood at Rs 699 crore in the quarter under review as compared to Rs 854 crore in the year-ago period, ...
- Wockhardt Q4 Results: Loss widens to Rs 311 crWockhardt had agreed to pay USD 36 million and interest over nine instalments between 2022 and 2025, the company said, adding its US subsid...
- Rakesh Jhujhunwala ups stake in this PSB, trims holding in WockhardtAccording to the latest filing from the lender, the Dalal Street veteran has bought 65 lakh shares of Canara Bank during January-March 2022...
- Wockhardt Q3 Results: Firm posts consolidated profit of Rs 1.77 crIncome from continuing operations rose to Rs 853.89 crore in the third quarter as against Rs 764.02 crore in the October-December period of...
- Wockhardt Q3 results: Net profit up 69% to Rs 32 croreTotal income stood at Rs 864.56 crore for the quarter under consideration, up 12.89 per cent, as against Rs 765.80 crore for the same perio...
- Wockhardt back in the black, posts Q3 profit of Rs 19 croreWockhardt had posted a net loss of Rs 76.86 crore for the corresponding period of 2018-19.
- Wockhardt plans to demerge its formulations biz, dilute stakeAt present, Khorakiwala himself is engaged in negotiations with a clutch of PE funds.
- Wockhardt shares jump nearly 10% as Q3 net profit risesWockhardt Ltd today reported 14.05 per cent increase in consolidated net profit at Rs 347.25 crore for the third quarter ended December 31,...
- Wockhardt Q3 net zooms two-fold to Rs 428 croreThe company had posted a net profit of Rs 213 crore in the same period of previous fiscal.
- Wockhardt to repay Rs 200 crore in FCCBs; Q1 net jumps 95%Wockhardt, which today reported 95 per cent jump in net profit in the June quarter, said it would repay the remaining Rs 200-crore of its o...
- Wockhardt hits 52-week high on strong Q1 resultsShares of Wockhardt surged over 6 per cent to hits its 52-week high of Rs 1084.60 after the company announced strong quarterly results.
- Wockhardt shares rises 8% on robust Q3 earningsShares of drug firm Wockhardt Ltd rose by 8% after the company's profit increased by 50.21 per cent for the quarter ended December 31, 2011
- Wockhardt Q3 net profit at Rs 141.67 crDrug firm Wockhardt Ltd today posted a consolidated net profit of Rs 141.67 crore for the third quarter ended December 31, 2010.
- Wockhardt Q1 FY 08 sales up 50 per cent at Rs 786 crorePharmaceutical and bio-tech major Wockhardt Ltd on Monday posted its consolidated sales for the first quarter ended March 31, 2008 at Rs 78...
Load More
